1Y Close · As of Aug 26, 2026
GENOLUTION operates in the Pharmaceuticals sector.
Legal name: GENOLUTION INC.
In fiscal year 2025, GENOLUTION (225220) reported revenue of 9.4 billion KRW, up 31.8% from 7.1 billion KRW a year earlier.
Operating profit was -8.6 billion KRW and net income was -12.6 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 26.5 billion KRW, with a P/B of 0.39.
These figures can be verified in the DART filing (receipt no. 20260319000806).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 9.4B | -8.6B | -12.6B |
| 2024 | 7.1B | -9.2B | -7.2B |
| 2023 | 9.8B | -7.1B | -5.6B |
Recent Filings
Officer/Major Shareholder Ownership Report
Officer/Major Shareholder Ownership Report
Officer/Major Shareholder Ownership Report
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-27 | Officer/Major Shareholder Ownership Report |